BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 12855769)

  • 1. The degradation of promyelocytic leukemia and Sp100 proteins by herpes simplex virus 1 is mediated by the ubiquitin-conjugating enzyme UbcH5a.
    Gu H; Roizman B
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8963-8. PubMed ID: 12855769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus 1-infected cell protein 0 contains two E3 ubiquitin ligase sites specific for different E2 ubiquitin-conjugating enzymes.
    Hagglund R; Van Sant C; Lopez P; Roizman B
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):631-6. PubMed ID: 11805320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two overlapping regions within the N-terminal half of the herpes simplex virus 1 E3 ubiquitin ligase ICP0 facilitate the degradation and dissociation of PML and dissociation of Sp100 from ND10.
    Perusina Lanfranca M; Mostafa HH; Davido DJ
    J Virol; 2013 Dec; 87(24):13287-96. PubMed ID: 24089549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential functions of interferon-upregulated Sp100 isoforms: herpes simplex virus type 1 promoter-based immediate-early gene suppression and PML protection from ICP0-mediated degradation.
    Negorev DG; Vladimirova OV; Maul GG
    J Virol; 2009 May; 83(10):5168-80. PubMed ID: 19279115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The two functions of herpes simplex virus 1 ICP0, inhibition of silencing by the CoREST/REST/HDAC complex and degradation of PML, are executed in tandem.
    Gu H; Roizman B
    J Virol; 2009 Jan; 83(1):181-7. PubMed ID: 18945770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PML plays both inimical and beneficial roles in HSV-1 replication.
    Xu P; Mallon S; Roizman B
    Proc Natl Acad Sci U S A; 2016 May; 113(21):E3022-8. PubMed ID: 27162364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alphaherpesvirus proteins related to herpes simplex virus type 1 ICP0 affect cellular structures and proteins.
    Parkinson J; Everett RD
    J Virol; 2000 Nov; 74(21):10006-17. PubMed ID: 11024129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of three redundant segments responsible for herpes simplex virus 1 ICP0 to fuse with ND10 nuclear bodies.
    Zheng Y; Gu H
    J Virol; 2015 Apr; 89(8):4214-26. PubMed ID: 25631093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The infected cell protein 0 of herpes simplex virus 1 dynamically interacts with proteasomes, binds and activates the cdc34 E2 ubiquitin-conjugating enzyme, and possesses in vitro E3 ubiquitin ligase activity.
    Van Sant C; Hagglund R; Lopez P; Roizman B
    Proc Natl Acad Sci U S A; 2001 Jul; 98(15):8815-20. PubMed ID: 11447293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the novel E3 ubiquitin ligase encoded in exon 3 of herpes simplex virus-1-infected cell protein 0.
    Hagglund R; Roizman B
    Proc Natl Acad Sci U S A; 2002 Jun; 99(12):7889-94. PubMed ID: 12060736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro.
    Boutell C; Sadis S; Everett RD
    J Virol; 2002 Jan; 76(2):841-50. PubMed ID: 11752173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PML contributes to a cellular mechanism of repression of herpes simplex virus type 1 infection that is inactivated by ICP0.
    Everett RD; Rechter S; Papior P; Tavalai N; Stamminger T; Orr A
    J Virol; 2006 Aug; 80(16):7995-8005. PubMed ID: 16873256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization of residues required for the herpes simplex virus 1 E3 ubiquitin ligase ICP0 to interact with the cellular E2 ubiquitin-conjugating enzyme UBE2D1 (UbcH5a).
    Vanni E; Gatherer D; Tong L; Everett RD; Boutell C
    J Virol; 2012 Jun; 86(11):6323-33. PubMed ID: 22438555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteins.
    Lopez P; Jacob RJ; Roizman B
    J Virol; 2002 Sep; 76(18):9355-67. PubMed ID: 12186918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-terminal phosphorylation sites of herpes simplex virus 1 ICP0 differentially regulate its activities and enhance viral replication.
    Mostafa HH; Thompson TW; Davido DJ
    J Virol; 2013 Feb; 87(4):2109-19. PubMed ID: 23221554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0.
    Boutell C; Orr A; Everett RD
    J Virol; 2003 Aug; 77(16):8686-94. PubMed ID: 12885887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication of ICP0-null mutant herpes simplex virus type 1 is restricted by both PML and Sp100.
    Everett RD; Parada C; Gripon P; Sirma H; Orr A
    J Virol; 2008 Mar; 82(6):2661-72. PubMed ID: 18160441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reciprocal activities between herpes simplex virus type 1 regulatory protein ICP0, a ubiquitin E3 ligase, and ubiquitin-specific protease USP7.
    Boutell C; Canning M; Orr A; Everett RD
    J Virol; 2005 Oct; 79(19):12342-54. PubMed ID: 16160161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression.
    Negorev DG; Vladimirova OV; Ivanov A; Rauscher F; Maul GG
    J Virol; 2006 Aug; 80(16):8019-29. PubMed ID: 16873258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex virus 1 mutant in which the ICP0 HUL-1 E3 ubiquitin ligase site is disrupted stabilizes cdc34 but degrades D-type cyclins and exhibits diminished neurotoxicity.
    Hagglund R; Roizman B
    J Virol; 2003 Dec; 77(24):13194-202. PubMed ID: 14645576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.